US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jul 21, 2023 (3 years ago)

Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations: Batch was released prior to approval.

What was recalled

Rufinamide Tablets, USP 200 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-616-08

Recalling firm
Aurobindo Pharma USA Inc.
NDC code
59651-616-08
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1087-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other East recalls

See all